These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34338267)

  • 1. ctc-[Pt(NH
    Li Y; Shi S; Zhang S; Gan Z; Wang X; Zhao X; Zhu Y; Cao M; Wang X; Li W
    Dalton Trans; 2021 Aug; 50(32):11180-11188. PubMed ID: 34338267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
    Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent Pt
    Ma L; Wang N; Ma R; Li C; Xu Z; Tse MK; Zhu G
    Angew Chem Int Ed Engl; 2018 Jul; 57(29):9098-9102. PubMed ID: 29806087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?
    Schmidt C; Babu T; Kostrhunova H; Timm A; Basu U; Ott I; Gandin V; Brabec V; Gibson D
    J Med Chem; 2021 Aug; 64(15):11364-11378. PubMed ID: 34342437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Arsenal of Pt
    Yempala T; Babu T; Karmakar S; Nemirovski A; Ishan M; Gandin V; Gibson D
    Angew Chem Int Ed Engl; 2019 Dec; 58(50):18218-18223. PubMed ID: 31599054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
    Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
    Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-releasing platinum(IV) prodrug efficiently inhibits proliferation and metastasis of cancer cells.
    Dai Y; Zhu Y; Cheng J; Shen J; Huang H; Liu M; Chen Z; Liu Y
    Chem Commun (Camb); 2020 Nov; 56(90):14051-14054. PubMed ID: 33103676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cis,cis,trans-[Pt
    Ravera M; Gabano E; Zanellato I; Rangone B; Perin E; Ferrari B; Bottone MG; Osella D
    Dalton Trans; 2021 Mar; 50(9):3161-3177. PubMed ID: 33595015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.
    Markova L; Maji M; Kostrhunova H; Novohradsky V; Kasparkova J; Gibson D; Brabec V
    J Med Chem; 2024 Jun; 67(11):9745-9758. PubMed ID: 38819023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
    Savino S; Gandin V; Hoeschele JD; Marzano C; Natile G; Margiotta N
    Dalton Trans; 2018 May; 47(21):7144-7158. PubMed ID: 29766157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP-1.
    Xu Z; Hu W; Wang Z; Gou S
    Eur J Med Chem; 2017 Dec; 141():211-220. PubMed ID: 29031068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
    Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pt(IV) Anticancer Prodrugs - A Tale of Mice and Men.
    Gibson D
    ChemMedChem; 2021 Jul; 16(14):2188-2191. PubMed ID: 33928760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative mechanism of action of the DNP Pt
    Krasnovskaya O; Spector D; Erofeev A; Gorelkin P; Akasov R; Skvortsov D; Trigub A; Vlasova K; Semkina A; Zyk N; Beloglazkina E; Majouga A
    Dalton Trans; 2021 Jun; 50(23):7922-7927. PubMed ID: 34037020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.
    Reshetnikov V; Arkhypov A; Julakanti PR; Mokhir A
    Dalton Trans; 2018 May; 47(19):6679-6682. PubMed ID: 29708261
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lee VEY; Lim ZC; Chew SL; Ang WH
    Inorg Chem; 2021 Feb; 60(3):1823-1831. PubMed ID: 33464875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dual Killing Strategy: Photocatalytic Generation of Singlet Oxygen with Concomitant Pt
    Norman DJ; Gambardella A; Mount AR; Murray AF; Bradley M
    Angew Chem Int Ed Engl; 2019 Oct; 58(40):14189-14192. PubMed ID: 31397963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
    Navas F; Chocarro-Calvo A; Iglesias-Hernández P; Fernández-García P; Morales V; García-Martínez JM; Sanz R; De la Vieja A; García-Jiménez C; García-Muñoz RA
    J Med Chem; 2024 Apr; 67(8):6410-6424. PubMed ID: 38592014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Anticancer Pt
    Kostrhunova H; Petruzzella E; Gibson D; Kasparkova J; Brabec V
    Chemistry; 2019 Apr; 25(20):5235-5245. PubMed ID: 30740808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery.
    Zheng YR; Suntharalingam K; Johnstone TC; Yoo H; Lin W; Brooks JG; Lippard SJ
    J Am Chem Soc; 2014 Jun; 136(24):8790-8. PubMed ID: 24902769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.